Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channels in coronary artery smooth muscle cells constitute a heterogeneous group of transmembrane proteins that regulate membrane potential and vascular tone by facilitating selective potassium ion flux across the cell membrane. These channels include several classes—voltage-dependent (KV), Ca²⁺-activated (KCa), inward rectifier (KIR), and ATP-sensitive (KATP)—each with distinct molecular properties and physiological roles. They are crucial in controlling vascular smooth muscle contraction, relaxation, and proliferation, affecting blood flow and arterial pressure. Dysregulation or pharmacological targeting of these channels is implicated in cardiovascular pathologies such as hypertension and ischemic heart disease[1][2][3].
Inhibition of potassium channels leads to membrane depolarization and vasoconstriction Activation of potassium channels induces membrane hyperpolarization and vasodilation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel in coronary artery smooth muscle cell (null).